跳至主要内容
临床试验/NCT06255860
NCT06255860已完成不适用

SARS-COV-2 (virus Responsible of COVID-19) Reinfection and Multisystem Inflammatory Syndrome in Children (MIS-C) Risk: Matched Case-control Study

Association Clinique Thérapeutique Infantile du val de Marne1 个研究点 分布在 1 个国家目标入组 204 人开始时间: 2023年9月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
204
试验地点
1
主要终点
proportion of MIS-C cases occurred after first SARS-CoV-2 infection

研究概览

简要总结

This study is a multicenter, international, non interventional, retrospective study about SARS-CoV-2 and Multisystem Inflammatory Syndrome (MIS-C) reinfection risk in children.

详细描述

This study is based to data collection of cases (patients with MIS-C) compare to controls (patients with SARS-CoV-2 infection) occurring between 01 sep 2021 and 30 apr 2022. For this study cases and controls group will be matched for analyses.

The main of this study is to evaluate the difference of risk of occurrence of MIS-C between a first SARS-CoV-2 infection and a reinfection with SARS-CoV-2.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
1 Day 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • group 1: cases
  • Patients with MIS-C (following SARS CoV-2 infection)
  • Hospitalised between the 01 sep 2021 and 30 apr 2022
  • Under 18 years of age
  • Not vaccinated for SARS-CoV-2
  • group 2: controls
  • Patients not hospitalised, treated by outpatient care
  • With documented SARS-CoV-2 infection between the 01 sep 2021 and 30 apr 2022
  • Matched with a case on age (+/- 6 months), gender and country
  • Not vaccinated for SARS-CoV-2

排除标准

  • Refusal to participate by patient relative or legal representative

结局指标

主要结局

proportion of MIS-C cases occurred after first SARS-CoV-2 infection

时间窗: 8 months

Assessment of risk of MIS-C after first SARS-CoV-2 infection

proportion of MIS-C cases occurred after SARS-CoV-2 reinfection

时间窗: 8 months

Assessment of risk of MIS-C after SARS-CoV-2 reinfection

Proportion of SARS-CoV-2 reinfection after first SARS-CoV-2 infection

时间窗: 8 months

Assessment of risk of SARS-CoV-2 reinfection after first SARS-CoV-2 infection

次要结局

未报告次要终点

研究者

发起方
Association Clinique Thérapeutique Infantile du val de Marne
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验